CYBER SECURE MEDICAL MANAGEMENT Seminar ppt.pptx

CYBER SECURE MEDICAL MANAGEMENT Seminar ppt.pptx

• 1.
  A CYBER SECUREMEDICAL MANAGEMENT SYSTEM BY USING BLOCKCHAIN
• 2.
  2 CONTENTS INTRODUCTION ABSTRACT ADVANTAGES DISADVANTAGES LITERATURE REVIEW METHODS DESIGN CONCLUSION FUTURE SCOPE
• 3.
  INTRODUCTION 3  Government Oversight: •Governmentmonitors supply chain, but oversight alone isn't sufficient.  Impact of Fake Drugs: •Fake drugs cause significant health issues; WHO reports high mortality rates in certain regions.  Complex Supply Chains: •The movement of drugs involves many steps and stakeholders. •Difficult to prevent counterfeit drugs from infiltrating the supply chain.
• 4.
  4  Transparency Challenges: •Difficultiesin maintaining visibility across the supply chain. •Issues with fake records and expired vaccines.  Health Risks: •Fake vaccines can pose serious health risks, including death. •Ensuring vaccine security is crucial for public health.  Need for Better Tracking: •Some regions have effective tracking (e.g., EU's IDMP standards), but it's not universal. •Strong supply chain management is needed to combat fake drugs.
• 5.
  5 ABSTRACT - Fake DrugsIssue: Problems with counterfeit drugs, especially vaccines, in the pharmaceutical industry. - Supply Chain Challenges: Lack of transparency, security, and traceability complicates management. - Online Pharmacies: Increase the risk of fake vaccines entering the supply chain. - TISVS Chain: A blockchain based system designed to enhance transparency security, and traceability. - Blockchain Flexibility: Works on both private and public blockchain tested on public blockchain with low resource use.
• 6.
  6 - Performance Testing:Evaluated on transaction speed, cost, and information dissemination. - Efficiency Enhancements: Uses special account addresses and optimizations to reduce gas costs and lost blocks. - Security Improvements: Implements offline unique account addresses to boost security. - Results: Demonstrated high transaction per second (TPS) rates and low propagation delay.
• 7.
  7 LITERATURE REVIEW AUTHORS TITLEFINDINGS Ibrahim Tariq Javed (LERO, The Irish software research center) Blockchain for Healthcare and Interoperability. • He has explored how blockchain can enhance the security and integrity of medical records. This includes decentralized data storage, which mitigates risks associated with centralized systems. Kashif Naseer Qureshi (University of Limerick) Cybersecurity Solutions and Risk Management • His research often focuses on developing innovative cybersecurity solutions that leverage blockchain for protecting sensitive medical data from unauthorized access and breaches. Tiziana Margaria (University of Limerick) Service-Oriented Architectures • She has extensively worked on service-oriented architectures, which can be foundational for understanding how blockchain can be integrated into healthcare systems for managing services securely.
• 8.
  8 METHODS Development Environment andTesting :  Used Remix IDE for virtual blockchain environment in browser.  Utilized Geth Visual Studio Code platform for private blockchain testing. TISVSchain Objectives :  Enhance security.  Improve transparency.  Ensure immutability.  Increase efficiency. TISVSchain Features :  Unique offline accounts.  Efficient Solidity smart contracts.
• 9.
  9 DESIGN • Smart contractsfor entity interaction • Unique offline account addresses • Solidity language (Remix IDE) • Geth, Visual Studio Code (private blockchain)
• 10.
  10
• 11.
  11 CONCLUSION • Automated detectionof manufacturing/expiry dates. • Reduced costs for regulatory authorities, manufacturers, and consumers. • Enhanced security and transparency. • Reduced counterfeiting. • Improved efficiency and scalability. • Enhanced consumer trust.
• 12.
  12 FUTURE SCOPE • Implementand validate TISVSchain on large-scale vaccine distribution programs. • Integrate IoT sensors for cold chain monitoring and temperature tracking. • Implement decentralized review and rating mechanisms for supply chain participants. • Capture immutable customer feedback logs for last-mile delivery performance. • Expand blockchain principles to manage supply chains of other temperature-sensitive pharmaceuticals.
• 13.
  13 REFERENCES: • [1] J.Dhandapani and R. Uthayakumar, “An EOQ model for a high cost and most wanted vaccine considering the expiration period,” J. Anal., vol. 27, no. 1, pp. 55–73, Mar. 2019. • [2] M. A. Qureshi, K. N. Qureshi, G. Jeon, and F. Piccialli, “Deep learningbased ambient assisted living for self-management of cardiovascular conditions,” Neural Comput. Appl., vol. 34, no. 13, pp. 10449–10467, Jul. 2022. • [3] U. H. Kartoglu, K. L. Moore, and J. S. Lloyd, “Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers,” Vaccine, vol. 38, no. 34, p. 5393, 2020. • [4] K. N. Qureshi, A. Ahmad, F. Piccialli, G. Casolla, and G. Jeon, “Natureinspired algorithm-based secure data dissemination framework for smart city networks,” Neural Comput. Appl., vol. 33, pp. 10637–10656, Apr. 2020. • [5] M. Uddin, “Blockchain medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry,” Int. J. Pharmaceutics, vol. 597, Mar. 2021, Art. no. 120235.
• 14.
  14 THANK YOU